[1] |
JIN Jing, CHENG Hong.
Research progress of mitochondrial energy metabolism involved in the pathogenesis of depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1193-1199.
|
[2] |
WANG Sijie,ZHANG Jun,LI Qian,HUANG Hua,WANG Jingjing,ZHOU Qiong,YAO Qin.
Research progress on the safety and effectiveness of escitalopram in the treatment of pregnant women with depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 1070-1074.
|
[3] |
CHEN Lianzhou, LI Songhua, PU Ben.
Effects of aripiprazole combined with escitalopram oxalate on DA, 5-HT and cortisol in patients with severe depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(4): 446-450.
|
[4] |
MO Yali, XIA Yong, LIU Yi, TAO Yunhai, JIN Man.
Effects of huperzine A combined with escitalopram on clinical efficacy and cognitive function in depression patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(9): 1040-1044.
|
[5] |
CHEN Jiaren, CUI Yudi, TIAN Hao, WANG Hao.
Vortioxetine for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 52-59.
|
[6] |
SHEN Zhong⁃xia, SHEN Xing⁃hua,CAI Min,FANG Yu,LIN Min, YANG Jian⁃hong, XU Yi.
Control research on fast up⁃titration of escitalopram in the treatment of generalized anxiety disorder
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(11): 1263-1267.
|
[7] |
LI Ya-ling, YE Jian-fei, LI Ting , LI Guo-rong.
The control research of escitalopram with or without eszopiclone on the treatment of generalized anxiety disorder with insomnia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(1): 54-57.
|
[8] |
SHEN Zhong-xia, GUAN Tie-feng, SHEN Xing-hua, QIAN Ming-cai, LIN Min, YANG Jian-hong.
The control research of escitalopram vs venlafaxine XR.on the treatment of generalized anxiety disorder
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(10): 1167-1171.
|
[9] |
XIA Jin-xiao, YAO Hua-hua, WANG Yi-bing, CAO Shi-lin, GAN Jian-guang, DUAN Di, LV Bo-jun.
Study on the escitalopram combined with low dose of aripiprazole in the treatment of depression with somatic symptoms
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(8): 929-932.
|
[10] |
JIANG Chang-wang, SHI Jian-fei , ZHU Ya-ping, TAO Yun-hai.
Efficacy study of Escitalopram together with atypical antipsychotic in treating depression symptoms accompanied with acute schizophrenia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(5): 574-578.
|
[11] |
WANG He-qiu, REN Zhi-bin, WANG Shu-zhen.
A clinical observation of escitalopram and venlafaxine-extended-release (XR) general in the treatment of outpatients with depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(10): 1174-1178.
|
[12] |
HUANG Zhen, MAO Qing-qiu, PAN Ai-juan, FENG Chun-rong, LI Zhao-yi, ZHONG Xiao-ming.
Effects of Suyu capsule on behaviors and hypothalamus-pituitary-adrenal axis in depression model rats induced by bilateral olfactory bulb impairment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(2): 163-166.
|
[13] |
TONG Jian-ming, LIU Cheng-wen, YANG Zheng-chun.
Open study of citalopram combined with doxepin in treating generalized anxiety disorder
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(8): 913-917.
|
[14] |
YANG Qian, LIU Wen-ying, ZHENG Feng, XU Ji-hua, RAO Jin-hua, SUN Di, GAO Shu.
A rapid and sensitive method for determination of escitalopram in human plasma and its application in pharmacokinetic study by liquid chromatography-tandem mass spectrometry
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(10): 1148-1153.
|